Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Pharmacol Res. 2017 Feb 7;119:219–226. doi: 10.1016/j.phrs.2017.01.034

Table 1.

Summary of bacteria studied in association with T1D

Bacteria Gram-positive or -negative Mode of action Protection from or acceleration of T1D References
SFB (Segmented filamentous bacteria), Candidatus Arthromitus positive Induce Th17 response Protection
No effect
38
27
Lactobacillus johnsonii & L. reuteri positive Healthy probiotics Protection 39, 81
Klebsiella pneumoniae negative Pathogen causing pneumonia Protection 41
Bifidobacterium positive Often as healthy probiotics Acceleration 6769
Streptococcus positive Some pathogens, some commensal bacteria in mouth, skin, intestine and upper respiratory tract Protection 40, 82
Akkermansia muciniphila negative Mucin-degrading, often anti-inflammatory effect Protection 52, 90
Bacteroides negative processing complex molecules to simpler compounds in the host intestine Acceleration 89, 90
Leptotrichia goodfellowii negative Oral commensal, pathogen in immune compromised patients Acceleration in NY8.3 NOD 46